# Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B

> **NCT00324961** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 533 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** adefovir dipivoxil tablets

## Key facts

- **NCT ID:** NCT00324961
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 533 (ACTUAL)
- **Last updated:** 2009-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324961, "Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00324961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*